Skip to main content

Bernocchi Perry A

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Bernocchi Perry A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 7, 2024 (view filing)Jun 61 dayBernocchi Perry AEVP, CEO,. Patient DirectSSale−20.0K$17.49−$350.0K−13.4%129.5K after4 lots10b5-1
May 3, 2024 (view filing)May 12 daysBernocchi Perry AEVP, CEO,. Patient DirectSSale−24.1K$24.31−$585.8K−12.4%170.5K after2 lots10b5-1
Nov 22, 2023 (view filing)Nov 22Same dayBernocchi Perry AEVP, CEO,. Patient DirectSSale−19.3K$18.75−$361.9K−10.5%164.3K after